Benzomorphans 19 and 21 were prepared in three steps
from enantiopure dihydropyridone 6a as shown in Scheme
3. N-Methylation of 6a gave a near quantitative yield of 17,
which on catalytic hydrogenation provided piperidinols 18
(>7:1, cis:trans) in good yield. A Grewe-type cyclization
Scheme 3
gave the target benzomorphan11b,12 19, [R]23 +116 (c 0.1,
D
CHCl3).
Alternatively, dihydropyridone 17 could be reduced with
L-Selectride in 87% yield to give piperidone 20, which on
treatment with HBr provided the enantiopure benzomorphan
21,11c [R]26 +24.6 (c 0.39, CHCl3).
D
The concise asymmetric syntheses of 4, 12, 13, 19, and
21 have amply demonstrated the versatility of our new
approach to benzomorphan derivatives using enantiopure 2,3-
dihydro-4-pyridones as chiral building blocks.13 The route
is practical as it uses the readily available chiral auxiliary
TCC, which can be prepared economically on a large scale
as either antipode6 and easily recycled.
Acknowledgment. We express appreciation to the
National Institutes of Health (Grant GM 34442) for financial
support of this research. Y.Z. also thanks the Burroughs
Wellcome Fund for a graduate fellowship.
Supporting Information Available: Characterization
data for compounds 4-9, 11, 14-15, and 17-21 and
comparison tables of NMR data for synthetic 4a,b, 19, and
21. This material is available free of charge via the Internet
OL990738P
(8) (a) Al-awar, R. S.; Joseph, S. P.; Comins, D. L. J. Org. Chem. 1993,
58, 7732. (b) Comins, D. L.; Green, G. M. Tetrahedron Lett. 1999, 40,
217.
(9) (a) Comins, D. L.; LaMunyon, D. H. Tetrahedron Lett. 1989, 30,
5053. (b) Comins, D. L.; Morgan, L. A. Tetrahedron Lett. 1991, 32, 5919.
(c) Waldmann, H.; Braun, M. J. Org. Chem. 1992, 57, 444. (d) Hattori, K.;
Yamamoto, H. J. Org. Chem. 1992, 57, 3264.
(10) (a) Imamoto, T.; Takiyama, N.; Nakamura, K.; Hatajima, T.;
Kamiya, Y. J. Am. Chem. Soc. 1989, 111, 4392. (b) Paquette, L. A.;
Thompson, R. C. J. Org. Chem. 1993, 58, 4952.
(11) (a) Takeda, M.; Jacobson, A. E.; Kanematsu, K.; May, E. L. J. Org.
Chem. 1969, 34, 4154. (b) Takeda, M.; Jacobson, A. E.; Kanematsu, K.;
May, E. L. J. Org. Chem. 1969, 34, 4158. (c) Takeda, M.; May, E. L. J.
Med. Chem. 1970, 13, 1223.
(12) (a) Craig, D.; McCague, R.; Potter, G. A.; Williams, M. R. V. Synlett
1998, 58. (b) Stella, L.; Raynier, B.; Surzur, J. M. Tetrahedron 1981, 37,
2843.
(13) The structure assigned to each new compound is in accordance with
its IR, 1H NMR, and 13C NMR spectra and elemental analysis or high-
resolution mass spectra.
(THF, reflux) provided a 91% yield of cis and trans
4-piperidinols 15 in a ratio of 2:1 with the trans 2,4-
disubstitued isomer as the major product. Determination of
stereochemistry at C-4 was assigned by an HOMO decoup-
ling experiment. The chemical shift of the axial proton at
C-4 is 3.48 ppm whereas the equatorial proton is found at
4.04 ppm. Conversion of 15 to benzomorphan 12 has been
reported by May using a Grewe-type carbocation cycliza-
tion.11 Subjection of 15 to pyridinium dichromate (PDC)
oxidation gave 1-methyl-4-piperidone 16 [R]23 +17.1 (c
D
0.21, CHCl3). Again, the last step leading to 2′,5-dihydroxy-
6,7-benzomorphan 13 is a literature procedure.11b Therefore,
analgesics 12 and 13 can be prepared from 2,3-dihydro-4-
pyridone 7 in a concise, asymmetric fashion.
Org. Lett., Vol. 1, No. 4, 1999
659